Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAES Smart Materials is a U.S.-based advanced materials company focused on the development, production, and sale of semi-finished nitinol products used primarily in the medical device industry. Its capabilities have included melting and manufacturing medical- and industrial-grade nitinol into forms such as wire, bar, ribbon, and sheet, supporting customers that make minimally invasive and implantable devices. The business was historically part of SAES Getters and operated as one of its U.S. shape memory alloy subsidiaries. In October 2023, SAES Smart Materials was acquired by Resonetics along with Memry Corporation, and the businesses were subsequently rebranded under Resonetics. For a healthcare analyst, this is best understood as a commercial medtech materials and manufacturing asset rather than a therapeutic biotech or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAES Smart Materials.